 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H23NO4 |
| Molar mass | 305.374 g·mol |
| 3D model (JSmol) | |
SMILES
| |
Cetraxate (INN) is an oral gastrointestinal medication which has a cytoprotective effect.
References
- Kurebayashi Y, Ikeda T, Osada Y (January 1988). "Cytoprotective action of cetraxate against HCl.ethanol-induced gastric lesion in rats". Jpn. J. Pharmacol. 46 (1): 17–25. doi:10.1254/jjp.46.17. PMID 3367546.
- Ishimori A, Yamagata S, Taima T (1979). "Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study". Arzneimittelforschung. 29 (10): 1625–32. PMID 391240.
| Drugs for peptic ulcer and GERD/GORD (A02B) | |
|---|---|
| H2 antagonists ("-tidine") | |
| Prostaglandins (E)/ analogues ("-prost-") | |
| Proton-pump inhibitors ("-prazole") | |
| Potassium-competitive acid blockers ("-prazan") | |
| Others | |
| Combinations | |
| |
 | This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |